Last reviewed · How we verify
NCT04919005
Virtual Environment to Aid Cognitive Stimulation of Elderly People With Early Alzheimer's
NA trial testing Virtual Environment in Alzheimer Disease in 34 participants. Completed in 20 July 2017.
30 April 2017
Quick facts
| Lead sponsor | University of Mogi das Cruzes |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 34 |
| Start date | 1 July 2016 |
| Primary completion | 30 April 2017 |
| Estimated completion | 20 July 2017 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Virtual Environment
Conditions studied
- Alzheimer Disease — all drugs for Alzheimer Disease →
Sponsor
University of Mogi das Cruzes
Who can join
Adults 19 to 99, any sex, with Alzheimer Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research was carried out with the objective of verifying the possibility of intervention through cognitive training protocols to assist in the stimulation of neurons and to delay the degradation resulting from Alzheimer's disease in its initial phase. The specific objective of this research was to develop and validate a virtual environment of games (called SorrisoTur) that allows the intervention of cognitive training.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04919005
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alzheimer Disease
Currently open trials in the same condition.
- NCT07290387 — Tele-Savvy for Latino Caregivers · NA · recruiting
- NCT07178210 — Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease · NA · recruiting
- NCT07294885 — Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's Disease · NA · recruiting
- NCT06937229 — A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) · Phase 3 · recruiting
- NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms · NA · recruiting
Other University of Mogi das Cruzes trials
Trials by the same sponsor.
- NCT04174690 — Balance Analysis System Through Biaxial Rotation Force Platform · NA · completed
- NCT04174729 — System for Quantifying the Functional Strength of the Grip and Pinch Movements · NA · completed
- NCT03743506 — An Instrumented Wobble Board to Present the Distribution and Center of Pressure in Dynamic Balance · NA · completed
- NCT03463447 — Measurement of Handgrip Strength and Pinch of Children and Adolescents Using an Electronic Dynamometer · NA · completed
- NCT03103048 — Application of Different Techniques of Elastic Bandage · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04919005 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Mogi das Cruzes
- Last refreshed: 9 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04919005.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing